Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

MMP inhibitors under investigation at Pharmacia & Upjohn

Aug. 27, 1998

FDA gives priority review status to COX-2 inhibitor

Aug. 27, 1998

Selective MMP-3 inhibitor PS-508 described at ACS meeting

Aug. 26, 1998

ACS news flash: Rhone-Poulenc Rorer studies dual PDE4/MMP inhibitors

Aug. 26, 1998

British Biotech claims MMP inhibitors for blocking connective tissue degradation

Aug. 26, 1998

FDA advisory committee meeting scheduled to review Enbrel BLA

Aug. 25, 1998

Mitsui Toatsu researches cell adhesion inhibitors for a range of potential indications

Aug. 21, 1998

Immune Response evaluates rheumatoid arthritis vaccine in follow-up trial

Aug. 21, 1998

Antiarthritic activity of cromoglicate lisetil in a model of immunologically-mediated disease

Aug. 20, 1998

Kotobuki also conducting research on COX-2 inhibitors

Aug. 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...